BioPharmSignal logoBioPharmSignal

Biotech News

Avenue Therapeutics to Participate in Maxim Group’s 2024 Healthcare Virtual Summit

Avenue Therapeutics (ATXI)Avenue TherapeuticsCompany update

ATXI (ATXI) appears in the live feed after a catalyst-style update. The headline is surfaced in real time so readers can move from signal to source without leaving the product flow.

The source domain is atxi.com. BioPharmSignal keeps the ticker, timestamp, and source together for faster review before the wider market catches up.

The original release is available below in a new tab so readers can continue into the full source when needed.

Related news

ATXIAvenue Therapeutics2024-09-03 12:30 EST

Avenue Therapeutics to Participate in Upcoming Investor Conferences

ATXIAvenue Therapeutics2024-06-20 12:30 EST

Avenue Therapeutics to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference

View all latest news

Avenue Therapeutics

Avenue Therapeutics is a specialty pharmaceutical company focused on acute and hospital-based pain management. Its story revolves around trying to bring differentiated pain treatments into controlled clinical settings.

Recent company news

ATXIAvenue Therapeutics2026-02-23 13:00 EST

Avenue Therapeutics Enters into Exclusive Worldwide License Agreement for ATX-04 for the Treatment of Pompe Disease

ATXIAvenue Therapeutics2025-11-06 12:00 EST

Avenue Therapeutics Announces Acquisition of Subsidiary Baergic Bio by Axsome Therapeutics

ATXIAvenue Therapeutics2024-11-14 21:05 EST

Avenue Therapeutics Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights

ATXIAvenue Therapeutics2024-10-09 12:30 EST

Avenue Therapeutics to Participate in Maxim Group’s 2024 Healthcare Virtual Summit

ATXIAvenue Therapeutics2024-09-03 12:30 EST

Avenue Therapeutics to Participate in Upcoming Investor Conferences

Stock data

Close
0.30 USD
Market cap
—
Exchange
NASDAQ
Sector
Biopharma
Location
United States